Where the Street stands
These are third-party analyst opinions from named firms, not advice, and not a prediction. How we score this
19 firms currently rating it, weighted by track record.
The 19 firms with a track record here beat the S&P 43% of the time over 12 months.
Pro: see the crowd-vs-sharp split for IBMAnalysts rate IBM a Buy with an average price target of $245.33, implying 13.4% upside from the current $216.28 level. The consensus spans 3 strong buys, 11 buys, and 9 holds against 2 sell ratings across 23 firms. Recent activity shows mixed signals: JPMorgan upgraded to Overweight in late June, but HSBC downgraded to Reduce on July 14, while most other firms have maintained their stances through July. IBM trades at a trailing P/E of 19.01 with modest revenue growth of 1.10% year-over-year and a declining EPS of -1.80%, though the company maintains a strong ROE of 34.46% and net margin of 15.52%. The stock has traded between $199.19 and $332.46 over the past 52 weeks with a beta of 0.68, indicating lower volatility relative to the broader market.
Generated from the data on this page; may contain errors. Analyst opinions belong to the named firms. Informational only, not investment advice.
| Date | Firm | Action | Rating |
|---|---|---|---|
| Jul 24, 2026 | Citigroup | ○ Maintained | |
| Jul 24, 2026 | Susquehanna | ○ Maintained |
Create a free account to unlock all analyst ratings, key stats, and news. No credit card, takes 30 seconds.
Sign up free